Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT06250257
Eligibility Criteria:
Inclusion Criteria:
* Women age 18 years to 50 years and
* ischemic or de novo dilated cardiomyopathy
Exclusion Criteria:
* Patients with severe comorbidities which may worsen their illness
* with hypertensive heart diseases
* Rheumatic valvular heart diseases
* Restrictive cardiomyopathy, constrictive cardiomyopathy, hypertrophic cardiomyopathy
* Congenital heart diseases
* Acute coronary syndrome
* Overt kidney failure (serum Creatinine ≥ 1.4mg/dl),
* Women who had history of peripartal cardiomyopathy, are pregnant or planning pregnancy during the study period or lactating
* Previous adverse reaction to the bromocriptine
* Patients not willing to participate in the study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT06250257
Study Brief:
Protocol Section:
NCT06250257